Medical research company Genomics Medicine Ireland (GMI) will go for an initial public offering within the next two years.
Based in Dublin, GMI was acquired by Chinese genomics specialists WuXi Nextcode last November. The value of the deal was not disclosed, but the company committed to investing $400 million to GMI’s plan to sequence the genomes of 400,000 people in Ireland.
It costs about $2,500 for each genome sequenced, so GMI’s plan to map the...
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Get a Business Account for you and your team